000			03264nam a22003615i 4500
001			82331
003			ES-MaUEC
005			20230207040407.0
007			cr nn 008mamaa
008			150525s2015 gw | s |||| 0|eng d
020			_a9783319158082
024	7		_a10.1007/978-3-319-15808-2 _2doi
050		4	_aRC682 _b2015 EB
245	1	0	_aCardiac Management of Oncology Patients : _bClinical Handbook for Cardio-Oncology _cedited by Gonzalo Baron Esquivias, Riccardo Asteggiano.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (IX, 259 páginas) _b65 ilustraciones, 58 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aIntroduction -- Physiopathology andÂ{u0D2F}xic drugs heart effects -- Radiotherapy heart effects -- Cardiac imaging technology in cardio-oncology -- Evaluation of the oncologic patient before, during and after chemotherapy -- What drug/what possible complication -- What cancer type/what possible drug -- what cancer/what possible complication -- Management (prevention/diagnosis/evaluation/therapy) of hypertension -- Management (prevention/diagnosis/evaluation/therapy) of coronary disease and thrombo-embolic complication -- Management (prevention/diagnosis/evaluation/therapy) of arrhythmic complication -- Management (prevention/diagnosis/evaluation/therapy) of systolic dysfunction.
520	3		_aIn recent years, progress in oncologic therapy has achieved important goals and a consequent prognostic improvement for patients with malignancy, but cardiac toxicity is often a concern and can have long-term functional or structural effects on the heart. This book is written for the cardiologist working in a clinical environment without support from a specific specialized cardio-oncologist team, and who are called to perform a clinical consultation to evaluate a cardiac condition and the eligibility for a patient to receive chemotherapy or radiotherapy. Cardiac Management of Oncology Patients: Clinical Handbook for Cardio-Oncology is also designed for oncologists and cardiologists to evaluate if a cancer treatment has produced toxic effects on a patient who has either recently or historically been treated with chemo or radiotherapy. The reader will discover more about the cardiac damage potentially created by the oncologic therapy that they are considering for the treatment of their patients.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aRadioterapia _2embne _9139979
650	2	7	_aRadioterapia _2embne _9139979
700	1		_aBaron Esquivias, Gonzalo _eeditor literario _944487
700	1		_aAsteggiano, Riccardo _eeditor literario _995192 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-15808-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12909713 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC682 .C373 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11577393 _z06-04-17
999			_c82331 _d82331 _x1